Date published: 2026-7-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

ARRDC4 Double Nickase Plasmid (h): sc-406413-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • ARRDC4 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • ARRDC4 Double Nickase Plasmid (h) and ARRDC4 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting ARRDC4. One or both designs may be available
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    ARRDC4 Double Nickase Plasmid (h)

    sc-406413-NIC
    20 µg
    $410.00

    ARRDC4 (arrestin domain containing 4) encodes a cytosolic adaptor protein in the α-arrestin family that binds membrane proteins and interfaces with ubiquitin-dependent trafficking pathways. ARRDC4 is implicated in endocytosis and cargo sorting by recruiting NEDD4-family E3 ubiquitin ligases, thereby influencing receptor turnover and signaling duration. Transcriptional regulation of ARRDC4 is linked to metabolic stress responses, including hypoxia- and nutrient-related programs, and it has been connected to modulation of glucose transport and cellular energy homeostasis. Altered ARRDC4 expression has been reported in contexts relevant to metabolic disease and cancer biology, making it a useful node for studying signaling adaptation and membrane protein quality control.

    ARRDC4 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the ARRDC4 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within ARRDC4. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt ARRDC4 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of ARRDC4-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.